| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 7e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.001 |